*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>N-Methyl Moxifloxacin is a synthetic fluoroquinolone antibiotic derivative featuring an N-methyl substitution on the piperazine ring, enhancing lipophilicity and tissue penetration. Its core synthesis involves coupling 1-cyclopropyl-6-fluoro-7-(4-methylpiperazin-1-yl)-8-methoxy-5,6-dihydro-2-oxo-1H-imidazo[1,2-a]pyridine-3-carboxylic acid with specific intermediates. <strong>Molecular Formula</strong>: C<sub>21</sub>H<sub>25</sub>FN<sub>4</sub>O<sub>4</sub>; <strong>CAS No.</strong>: 151096-09-2.</p>
<h3>Application</h3>
<ul>
<li>Pharmaceutical API manufacturing for advanced respiratory tract infection therapies.</li>
<li>Research and development of novel antibacterial agents targeting resistant strains.</li>
<li>Veterinary medicine formulations for treating bacterial infections in livestock.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly avoid use in patients with known hypersensitivity to quinolones or during pregnancy due to cartilage toxicity risks. Store in sealed containers at controlled temperatures between 2°C and 8°C away from direct sunlight to maintain chemical stability and prevent degradation.</p>